Sandoz to acquire Just–Evotec Biologics facility for $300 million
The companies will now begin detailed contract negotiations and proceed with necessary consultations and approval processes
The companies will now begin detailed contract negotiations and proceed with necessary consultations and approval processes
Upgrades 2025 full-year CDMO sales and margin outlook
Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in the US
Investment builds on Biogen’s 30-year history of manufacturing in the region, with approximately $10 billion invested to date
India’s fertility rate has dropped to 1.9, below the replacement level of 2.1
ISG acknowledged Indegene's strengths in implementing holistic creative workflows, interoperability via robust integration with tech ecosystems
Extended lab space for product development, customer demos, and training
Star Health Insurance is modernising its claims ecosystem to be future-ready
QuantumNexis will serve as the innovative engine for HCTI's recurring revenue business lines
Integrated facility to deliver end-to-end, customized workflows across life sciences, diagnostics, and applied markets
 
        Subscribe To Our Newsletter & Stay Updated